1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,044 | 0,066 | 11:27 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.11. | Hvivo client acquired by MSD in $9.2bn deal | 8 | Sharecast | ||
| 27.11. | hVIVO PLC - MSD to acquire Cidara | 13 | RNS | ||
| 20.11. | hVIVO PLC - >£5 million CRS contracts signed | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 11.11. | hVIVO develops three new human challenge models for viral testing | 3 | Investing.com | ||
| 11.11. | hVIVO meldet erfolgreiche Entwicklung von drei neuen humanen Challenge-Modellen | 1 | Investing.com Deutsch | ||
| 11.11. | hVIVO PLC - Positive data from novel human challenge models | - | RNS | ||
| 03.11. | hVIVO PLC - Presentation at Jefferies Healthcare Conference | - | RNS | ||
| 23.09. | HVIVO Slides To Loss In H1 | - | RTTNews | ||
| 23.09. | hVIVO PLC - Interim results | - | RNS | ||
| 04.09. | hVIVO PLC - Notice of Results | 4 | RNS | ||
| 01.09. | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
| 01.09. | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| 22.07. | hVIVO PLC - H1 Trading update | 1 | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 27.01. | ILiAD Biotechnologies, LLC: ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting | 298 | Business Wire | Trial anticipated for H2 2025 to evaluate most advanced next generation intranasal pertussis vaccine for whooping cough
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,628 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Highlights Three REYOBIQ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 6,600 | 0,00 % | JD HEALTH, Wuhan University People's Hospital Explore New Integrated Development Model | ||
| LIFEWARD | 0,691 | 0,00 % | Lifeward Ltd. Reports Third Quarter 2025 Financial Results | Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27%... ► Artikel lesen | |
| EKSO BIONICS | 4,420 | 0,00 % | Ekso Bionics Stock Drops 13% Despite After Company Becomes Exclusive U.S. Distributor | ||
| IMUNON | 3,480 | +2,96 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,767 | -8,31 % | Rockwell Medical appoints Joe Dawson to board of directors | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 28,220 | +3,03 % | Viridian Therapeutics: Strategische Fortschritte bei TED- und FcRn-Programmen | ||
| SINTX TECHNOLOGIES | 4,210 | 0,00 % | SINTX Tech stock price target lowered to $16 from $25 at Ascendiant | ||
| AETHLON MEDICAL | 3,940 | 0,00 % | Morning Market Movers: Powell Max, Kaixin Holdings, Acadia Healthcare, Aethlon Medical See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| SAVARIA | 13,600 | +0,74 % | Dividendenbekanntmachungen (28.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1034 EUR AGREE REALTY CORPORATION US0084921008 0,262 USD 0,2259 EUR ALLIED PROPERTIES... ► Artikel lesen | |
| NEURONETICS | 1,172 | +5,21 % | Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan | Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of... ► Artikel lesen |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.